Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

H. Ramdani, M. Falk, S. Schatz, M. Tiemann, L. Heukamp, E. Schuuring, H. Groen, F. Griesinger

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S732-S733
Number of pages2
JournalJournal of Thoracic Oncology
Volume14
Issue number10
DOIs
Publication statusPublished - Oct-2019

Keywords

  • NSCLC
  • Immune Checkpoint Inhibitors
  • tumor mutational burden

Cite this